In the randomized African-American Study of Kidney Disease and Hypertension Trial, CYP3A5 rs776746, unlike CYP3A4 variants, was not associated with blood pressure response to amlodipine [90]. This evidence concerns the gene CYP3A5 and hypertensive disorder.